Our findings emphasize that obesity, as reflected by higher BMI and WC, and other metabolic factors, such as increased ALT, AST, GGT, and HbA1c levels, were more prevalent in NAFLD patients with LF compared to those without. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.